Trevi Therapeutics, Inc. (TRVI)
NASDAQ: TRVI · IEX Real-Time Price · USD
2.780
+0.120 (4.51%)
At close: Jul 19, 2024, 4:00 PM
2.760
-0.020 (-0.72%)
Pre-market: Jul 20, 2024, 9:28 AM EDT
Trevi Therapeutics Market Cap
Trevi Therapeutics has a market cap or net worth of $195.81 million as of July 22, 2024. Its market cap has increased by 43.56% in one year.
Market Cap
195.81M
Enterprise Value
124.26M
1-Year Change
43.56%
Ranking
Category
Stock Price
$2.78
Market Cap Chart
Since May 7, 2019, Trevi Therapeutics's market cap has increased from $140.20M to $195.81M, an increase of 39.66%. That is a compound annual growth rate of 6.63%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 19, 2024 | 195.80M | 128.74% |
| Dec 29, 2023 | 85.60M | -26.02% |
| Dec 30, 2022 | 115.70M | 472.77% |
| Dec 31, 2021 | 20.20M | -54.61% |
| Dec 31, 2020 | 44.50M | -33.48% |
| Dec 31, 2019 | 66.90M | -52.28% |
View and export this data all the way back to 2019.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| CVRx, Inc. | 202.13M |
| Outset Medical | 200.17M |
| Personalis | 199.96M |
| Renovaro Biosciences | 199.13M |
| P3 Health Partners | 197.60M |
| ClearPoint Neuro | 193.86M |
| Generation Bio Co. | 191.60M |
| Greenwich LifeSciences | 191.01M |